Executive team

Agustin Fernandez


Chief Executive Officer

David Brindley, DPhil, MEng; PG Cert, (IP), RAC (US), FRSA, FRSB


Chief Operating Officer

Edward Gershburg, PhD


Chief Technology Officer

Luis Rios-Nogales, MD, PhD, MBA


Chief Development and Medical Officer

Kelly Smith MD, MHS


Global Safety Officer

Gerhard Hager, PhD


Head of Non-Clinical Development

Uwe Michaelis, PhD


IMPD Submission Operations

Kerstin Westritschnig, MD


Head of Clinical Development

Konstantin Kousoulas PhD


VP of Scientific Affairs

Cecilia Huaman, MPH, Ph.D


Director Immunology and Diagnostics

Christian Wallasch, PhD


Head, Global Operations

Quinn Steele


Head of GxP and Regulatory E-Systems

Diane Abbitt, Esq


Patient Advocate

David B. Mixner


Diversity Outreach Advisor

Scientific Advisory Board

Paul Predki, PhD


SAB Chair, Biotech executive, co-founder and CTO of Iridia Inc.

Rahul Singhvi, ScD, MBA


Operating Partner, Flagship Pioneering

Lional Raj, MD


Medical Director, Department of Cornea and Refractive Surgery, Dr. Agarwal’s Eye Hospital, India

Daniel J.J. Carr, PhD


Dean of Research, McGee Eye Institute and Optometry, University of Oklahoma, USA

Georg Holländer, MA, MD, FMedSci, FRCPCH, FHM Pediatrics


Chair, Department of Pediatrics, University of Oxford, Oxford, UK

Todd Margolis, MD, PhD


Chair, Department of Ophthalmology, Washington University, St. Louis, MO, USA

Jim Robinson, BS, MS


Industry Consultant

David I. Bernstein, MD, MA